EMAIL THIS PAGE TO A FRIEND

Anticancer Research

Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs).


PMID 25503127

Abstract

We're sorry this abstract is currently not available.